AGENDA   

The inaugural Microbiome World Congress Americas 2017 will bring together leading pharma, biotechs, academic researchers, and their partners to Washington DC in order to discuss how to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.

 

Leading the discussion at our 2017 event includes: ‚Äč

  • Jack Gilbert,  Faculty Director,  The Microbiome Center,  Professor, Department of Surgery,  The University of Chicago  , Senior Scientist (Adjunct),  the Marine Biological Laboratory  , Group Leader in Microbial Ecology,  Argonne National Laboratory 

  • Carrie Brodmerkel,  Director of Immunology Biomarkers,  Janssen

  • Nikola Trbovic,  PhD, Director R &D Technology Strategy,  Pfizer

  • Paul E. Carlson Jr.,  PhD, Principal investigator, Laboratory of Mucosal Pathogens and Cellular Immunology, CBER/OVRR,  U.S. Food and Drug Administration

  • Kathleen Basmadjian,  Senior Director, Global Regulatory Policy & Intelligence, Global Regulatory Affairs,  Janssen R & D

  • Jim Brown,  Director, Computational Biology, Senior Fellow,  GlaxoSmithKline

  • Matt Henn,  Senior VP, Head of Drug Discovery and Bioinformatics,  Seres Therapeutics

  • Elaine Hsiao,  PhD, Assistant Professor, Department of Integrative Biology & Physiology,  UCLA

  • and 50+ industry leaders.  Click here to see the full speaker list >>